Mangoceuticals (NASDAQ:MGRX) Acquires Patents for Nutraceutical Compositions and Implements Corporate Restructuring to Enhance Operations

Mangoceuticals, Inc., a Texas corporation traded on Nasdaq under the symbol MGRX, recently disclosed a series of significant corporate developments in an 8-K filing with the U.S. Securities and Exchange Commission on December 13, 2024. The company finalized a Patent Purchase Agreement with Greenfield Investments, Ltd, entailing the acquisition of patents related to nutraceutical compositions […]

Leave a Reply

Your email address will not be published.

Previous post Mayne Pharma Group (OTCMKTS:MAYNF) Trading Down 0.5% – Here’s What Happened
Next post Minnesota now allowing advanced payments for child tax credit recipients